IRM
Overvalued by 129.2% based on the discounted cash flow analysis.
Market cap | $24.04 Billion |
---|---|
Enterprise Value | $36.55 Billion |
Dividend Yield | $2.5346 (3.09%) |
Earnings per Share | $0.66 |
Beta | 1.09 |
Outstanding Shares | 293,133,321 |
Avg 30 Day Volume | 1,291,881 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 124.09 |
---|---|
PEG | 846.8 |
Price to Sales | 4.3 |
Price to Book Ratio | - |
Enterprise Value to Revenue | 6.48 |
Enterprise Value to EBIT | 32.11 |
Enterprise Value to Net Income | 188 |
Total Debt to Enterprise | 0.35 |
Debt to Equity | 685.59 |
No data
No data